"Designing Growth Strategies is in our DNA"

Veterinary Point-of-Care Diagnostics Market Size, Share and Analysis by Types (kit, Instruments), Application (Hormone Level Testing, Infectious Disease Testing), End Users (Veterinary Hospitals, Home Care Settings, Veterinary Clinics) and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI100362

 

Veterinary Point-of-Care Diagnostics Market Overview

The global veterinary point of care diagnostics market size was valued at USD 624.75 billion in 2025. The market is projected to grow from USD 680.76 billion in 2026 to USD 1353.11 billion by 2034, exhibiting a CAGR of 8.97% during the forecast period.

The Veterinary Point-of-Care Diagnostics Market plays a critical role in enabling rapid, on-site diagnostic testing for animals across clinical and non-clinical settings. These diagnostic solutions allow veterinarians to make immediate treatment decisions without relying on centralized laboratories. The market includes portable diagnostic kits and compact instruments designed for quick detection of infections, metabolic disorders, hormonal imbalances, and chronic conditions. Rising demand for real-time diagnostics, increased pet ownership, and the growing emphasis on preventive veterinary care are driving adoption. The Veterinary Point-of-Care Diagnostics Market Size continues to expand as clinics seek faster turnaround times, operational efficiency, and improved patient outcomes, reinforcing strong demand across companion and livestock animal healthcare.

The United States represents the most mature and technologically advanced Veterinary Point-of-Care Diagnostics Market. High pet ownership levels, advanced veterinary infrastructure, and widespread awareness of preventive animal healthcare support strong adoption. Veterinary hospitals and clinics increasingly rely on point-of-care diagnostic kits and instruments to deliver immediate results. The Veterinary Point-of-Care Diagnostics Market Analysis highlights strong demand for infectious disease testing and hormone-level diagnostics in companion animals. Growing acceptance of in-clinic testing improves workflow efficiency and client satisfaction. Rapid adoption of portable diagnostic technologies, combined with strong purchasing power, positions the USA as a key contributor to overall Veterinary Point-of-Care Diagnostics Market Growth.

Key Findings

Market Size & Growth

  • Global Market Size 2025: USD 624.75 billion
  • Global Market Forecast 2034: USD 1353.11 billion
  • CAGR (2025–2034): 8.97%

Market Share – Regional

  • North America: 38%
  • Europe: 27%
  • Asia-Pacific: 22%
  • Rest of the World: 13%

Country-Level Shares

  • Germany: 9% of Europe’s market 
  • United Kingdom: 8% of Europe’s market 
  • Japan: 6% of Asia-Pacific market 
  • China: 8% of Asia-Pacific market 

Veterinary Point-of-Care Diagnostics Market Latest Trends

The Veterinary Point-of-Care Diagnostics Market Trends indicate a clear shift toward decentralized, rapid diagnostic testing solutions. Veterinary clinics increasingly prefer compact, easy-to-use diagnostic devices that deliver accurate results within minutes. One major trend is the growing adoption of multi-analyte diagnostic kits capable of detecting multiple conditions from a single sample. Digital integration with clinic management software is improving data accessibility and clinical decision-making. The Veterinary Point-of-Care Diagnostics Market Research Report highlights increasing demand for infectious disease screening due to rising zoonotic risk awareness. Home-based diagnostic solutions for chronic condition monitoring are gaining traction. Advancements in biosensor technology are improving test sensitivity and specificity. Additionally, manufacturers are focusing on user-friendly designs requiring minimal technical training. These trends collectively strengthen the Veterinary Point-of-Care Diagnostics Market Outlook.

Download Free sample to learn more about this report.

Veterinary Point-of-Care Diagnostics Market Dynamics

DRIVER

Rising demand for rapid and on-site veterinary diagnostics

The primary driver of the Veterinary Point-of-Care Diagnostics Market Growth is the increasing demand for immediate diagnostic results in veterinary practice. Veterinarians require quick test outcomes to initiate timely treatment and reduce disease progression. Growing pet humanization trends encourage owners to seek immediate care solutions. Point-of-care diagnostics eliminate delays associated with external laboratory testing. The Veterinary Point-of-Care Diagnostics Market Insights highlight strong adoption in emergency care and routine wellness screening. Increased prevalence of infectious diseases in animals further accelerates testing demand. Livestock health management also benefits from rapid on-site diagnostics. Improved diagnostic accuracy supports evidence-based treatment. Reduced turnaround time enhances clinical efficiency. This driver continues to fuel sustained expansion across the Veterinary Point-of-Care Diagnostics Industry.

RESTRAINT

Limited accuracy compared to centralized laboratory testing

A significant restraint in the Veterinary Point-of-Care Diagnostics Market is the perceived limitation in diagnostic accuracy compared to reference laboratories. Some point-of-care tests may provide preliminary rather than confirmatory results. Variability in test performance across animal species can impact clinical confidence. The Veterinary Point-of-Care Diagnostics Market Analysis highlights concerns over false positives and negatives in certain rapid tests. Calibration and quality control requirements increase operational complexity. Smaller clinics may lack trained staff for advanced device handling. Regulatory compliance varies across regions. These factors can slow adoption in highly specialized diagnostic scenarios. Despite improvements in technology, accuracy concerns remain a limiting factor for broader market penetration.

OPPORTUNITY

Expansion of home-based and remote veterinary diagnostics

The expansion of home-based veterinary diagnostics represents a major opportunity within the Veterinary Point-of-Care Diagnostics Market. Increasing demand for at-home pet care solutions is driving innovation in portable and easy-to-use diagnostic kits. Chronic disease monitoring, hormone testing, and wellness screening are well-suited for home settings. The Veterinary Point-of-Care Diagnostics Market Forecast indicates rising interest in remote diagnostics supported by digital platforms. Pet owners value convenience and reduced clinic visits. Tele-veterinary services further enhance adoption potential. Manufacturers are developing simplified testing solutions requiring minimal handling. This opportunity supports long-term growth and diversification across the Veterinary Point-of-Care Diagnostics Industry.

CHALLENGE

High initial investment and device maintenance costs

High initial investment and ongoing maintenance costs present a major challenge in the Veterinary Point-of-Care Diagnostics Market. Diagnostic instruments require regular calibration, consumables, and software updates. Smaller clinics and rural veterinary practices may face budget constraints. The Veterinary Point-of-Care Diagnostics Industry Analysis highlights cost sensitivity as a key adoption barrier. Training requirements add to operational expenses. Replacement of consumables increases long-term costs. Pricing pressure impacts purchasing decisions in emerging markets. Managing device downtime affects workflow efficiency. Addressing affordability and cost-effectiveness remains critical for wider adoption and sustained Veterinary Point-of-Care Diagnostics Market Growth.

Veterinary Point-of-Care Diagnostics Market Segmentation

Market share analysis shows that the Veterinary Point-of-Care Diagnostics Market is segmented based on product type, diagnostic application, and end-user setting. This segmentation reflects differences in testing complexity, speed requirements, cost considerations, and care delivery environments. Product-based segmentation highlights the balance between disposable diagnostic kits and reusable diagnostic instruments. Application-based segmentation captures the increasing focus on hormone monitoring and infectious disease detection. End-user segmentation illustrates how diagnostic adoption varies across veterinary hospitals, clinics, and home care settings. Together, these segments define purchasing behavior, technology adoption, and growth patterns across the Veterinary Point-of-Care Diagnostics Industry.

By Type

Diagnostic kits account for approximately 58% of the global Veterinary Point-of-Care Diagnostics Market share, making them the dominant product type. These kits are widely used due to their affordability, ease of use, and rapid result delivery. Veterinary professionals rely on point-of-care kits for routine screening, infectious disease detection, and wellness testing. The Veterinary Point-of-Care Diagnostics Market Analysis highlights strong demand for disposable kits that require minimal equipment and training. Kits are particularly favored in small clinics and mobile veterinary practices. Their portability supports on-site testing in field conditions. High test throughput enhances operational efficiency. Regular repeat purchases drive consistent demand. Compatibility with multiple animal species improves adoption. This segment remains the primary contributor to Veterinary Point-of-Care Diagnostics Market Growth.

Diagnostic instruments represent approximately 42% of the Veterinary Point-of-Care Diagnostics Market share and play a critical role in advanced in-clinic testing. These instruments offer higher accuracy, multi-parameter testing, and digital result integration. Veterinary hospitals and large clinics prefer instruments for comprehensive diagnostic evaluation. The Veterinary Point-of-Care Diagnostics Industry Report highlights increasing adoption of compact analyzers for blood chemistry and hormone analysis. Instruments support faster clinical decision-making compared to external labs. Initial investment costs are higher but offset by long-term efficiency gains. Integration with practice management systems improves workflow. Regular software upgrades enhance performance. Instruments are essential for high-volume testing environments. This segment continues to expand with technological advancement.

By Application

Hormone level testing accounts for approximately 47% of the Veterinary Point-of-Care Diagnostics Market share, driven by rising prevalence of endocrine disorders in animals. Conditions such as diabetes, thyroid disorders, and adrenal diseases require frequent monitoring. Veterinary point-of-care diagnostics enable rapid hormone assessment during clinical visits. The Veterinary Point-of-Care Diagnostics Market Insights highlight strong adoption in companion animal care. Immediate test results support timely treatment adjustments. Hormone testing is increasingly used in preventive wellness programs. Compact analyzers and kits improve testing accessibility. Demand is high in chronic disease management. Pet owners value same-visit diagnosis. This application segment remains a key driver of Veterinary Point-of-Care Diagnostics Market Size.

Infectious disease testing represents approximately 53% of the Veterinary Point-of-Care Diagnostics Market share and is the largest application segment. Rising incidence of contagious animal diseases drives strong demand. Rapid detection supports timely isolation and treatment. The Veterinary Point-of-Care Diagnostics Market Research Report highlights growing concern over zoonotic disease transmission. Point-of-care tests are widely used for viral, bacterial, and parasitic infections. Livestock and companion animal sectors both contribute to demand. On-site testing reduces disease spread risks. Emergency care settings heavily rely on infectious disease diagnostics. High testing frequency supports sustained growth. This segment remains central to the Veterinary Point-of-Care Diagnostics Industry.

By End User

Veterinary hospitals account for approximately 46% of the Veterinary Point-of-Care Diagnostics Market share due to high patient volumes and advanced diagnostic capabilities. These settings require rapid, accurate testing to support complex case management. Hospitals invest in both diagnostic kits and instruments. The Veterinary Point-of-Care Diagnostics Market Analysis highlights strong use in emergency and critical care. In-house diagnostics improve turnaround time and treatment outcomes. Trained staff support advanced device operation. High capital availability enables technology adoption. Integration with hospital information systems enhances efficiency. Hospitals remain the largest end-user segment. This segment continues to anchor Veterinary Point-of-Care Diagnostics Market Outlook.

Home care settings represent approximately 19% of the Veterinary Point-of-Care Diagnostics Market share and are an emerging segment. Growth is driven by increasing demand for at-home pet care and chronic disease monitoring. Simple diagnostic kits enable pet owners to perform basic testing. The Veterinary Point-of-Care Diagnostics Market Forecast highlights rising adoption of remote diagnostics. Tele-veterinary services complement home testing solutions. Convenience and reduced clinic visits drive demand. Manufacturers are developing user-friendly kits for non-professional use. Accuracy improvements enhance trust. Regulatory oversight influences product availability. This segment offers strong future Veterinary Point-of-Care Diagnostics Market Opportunities.

Veterinary clinics account for approximately 35% of the Veterinary Point-of-Care Diagnostics Market share and represent a core adoption segment. Clinics rely on point-of-care diagnostics to streamline workflow and improve client satisfaction. Rapid testing supports same-day diagnosis and treatment initiation. The Veterinary Point-of-Care Diagnostics Industry Analysis highlights widespread use of kits and compact instruments. Cost efficiency influences purchasing decisions. Clinics prioritize diagnostics with minimal training requirements. Preventive care programs drive routine testing demand. In-clinic diagnostics reduce dependency on external labs. Growing clinic networks support scale adoption. This segment remains essential to Veterinary Point-of-Care Diagnostics Market Growth.

Veterinary Point-of-Care Diagnostics Market Regional Outlook

North America

North America accounts for approximately 38% of the global Veterinary Point-of-Care Diagnostics Market share, making it the largest regional contributor. The region benefits from a well-developed veterinary healthcare ecosystem and high penetration of in-clinic diagnostic technologies. Strong pet ownership trends and increased spending on preventive animal care support adoption. The Veterinary Point-of-Care Diagnostics Market Analysis highlights widespread use of diagnostic kits and instruments in veterinary hospitals and clinics. Emergency care and routine wellness screening drive frequent test utilization. Advanced training among veterinary professionals supports accurate device usage. Integration of diagnostics with digital practice management systems enhances workflow efficiency. Livestock diagnostics also contribute to market demand. Regulatory support ensures product quality and safety. North America remains the most mature and innovation-driven Veterinary Point-of-Care Diagnostics Market.

Europe

Europe represents approximately 27% of the global Veterinary Point-of-Care Diagnostics Market share, supported by strong regulatory frameworks and established veterinary healthcare systems. The region places high emphasis on animal welfare and disease prevention. Veterinary clinics across Europe increasingly adopt point-of-care diagnostics to reduce turnaround time. The Veterinary Point-of-Care Diagnostics Market Research Report highlights steady demand for infectious disease testing and hormone analysis. Public and private veterinary services contribute to consistent testing volumes. Structured livestock health monitoring programs support adoption. Technological advancements improve test accuracy and usability. Cost containment influences purchasing decisions in some countries. Growing awareness of zoonotic diseases strengthens demand. Europe remains a stable and regulation-driven Veterinary Point-of-Care Diagnostics Market.

Germany Veterinary Point-of-Care Diagnostics Market

Germany accounts for approximately 9% of the global Veterinary Point-of-Care Diagnostics Market share and is one of the leading European markets. The country benefits from advanced veterinary practices and strong diagnostic standards. Veterinary hospitals and large clinics drive adoption of diagnostic instruments. The Veterinary Point-of-Care Diagnostics Market Analysis highlights high utilization of hormone and infectious disease testing. Strong collaboration between academic institutions and veterinary providers supports innovation. Pet owners show high awareness of preventive diagnostics. Livestock health monitoring also contributes to demand. Regulatory compliance ensures product reliability. Investment in digital veterinary solutions enhances workflow efficiency. Germany remains a key precision-focused market within Europe.

United Kingdom Veterinary Point-of-Care Diagnostics Market

The United Kingdom holds approximately 8% of the global Veterinary Point-of-Care Diagnostics Market share, driven by strong focus on companion animal healthcare. Veterinary clinics increasingly rely on point-of-care diagnostics to support same-day treatment decisions. The Veterinary Point-of-Care Diagnostics Market Insights highlight growing use of rapid testing kits. High pet insurance coverage improves diagnostic affordability. Preventive care programs encourage routine screening. Referral networks support advanced diagnostics adoption. Regulatory oversight ensures diagnostic quality. Growing awareness of chronic disease management supports hormone testing demand. Digital integration improves clinical efficiency. The UK remains an important and steadily growing market within Europe.

Asia-Pacific

Asia-Pacific accounts for approximately 22% of the global Veterinary Point-of-Care Diagnostics Market share and represents the fastest-growing regional segment. Rising urbanization and increasing pet ownership drive demand for veterinary diagnostics. The Veterinary Point-of-Care Diagnostics Market Outlook highlights expanding veterinary infrastructure across major cities. Livestock population growth supports demand for rapid disease detection. Governments are investing in animal health and food safety programs. Adoption of diagnostic kits leads the market due to cost efficiency. Awareness of preventive animal care is improving. Training initiatives support device adoption. Price sensitivity influences purchasing decisions. Asia-Pacific offers strong long-term Veterinary Point-of-Care Diagnostics Market Opportunities.

Japan Veterinary Point-of-Care Diagnostics Market

Japan represents approximately 6% of the global Veterinary Point-of-Care Diagnostics Market share, characterized by advanced veterinary standards and technological sophistication. The country emphasizes precision diagnostics and quality animal healthcare. The Veterinary Point-of-Care Diagnostics Market Analysis highlights strong adoption of compact diagnostic instruments. Aging pet populations increase demand for chronic disease monitoring. High awareness of preventive care supports routine testing. Veterinary clinics prioritize accuracy and reliability. Digital health integration improves diagnostic workflows. Regulatory frameworks ensure product safety. Innovation in diagnostic devices supports adoption. Japan remains a technologically advanced and specialized market.

China Veterinary Point-of-Care Diagnostics Market

China accounts for approximately 8% of the global Veterinary Point-of-Care Diagnostics Market share, driven by rapid growth in urban pet ownership. Expanding middle-class income levels support increased spending on pet healthcare. The Veterinary Point-of-Care Diagnostics Market Report highlights rising establishment of modern veterinary clinics. Infectious disease testing dominates adoption due to population density concerns. Government initiatives improve animal health infrastructure. Domestic manufacturing supports product availability. Awareness of point-of-care diagnostics is improving. Training programs enhance professional capacity. Cost considerations influence technology selection. China continues to emerge as a key growth market in Asia-Pacific.

Rest of the World

Rest of the World accounts for approximately 13% of the global Veterinary Point-of-Care Diagnostics Market share and shows gradual expansion. Growth is driven by increasing focus on livestock health and food security. Veterinary services are expanding in urban centers. The Veterinary Point-of-Care Diagnostics Market Insights highlight reliance on rapid diagnostic kits. Limited access to advanced instruments restricts adoption in rural areas. Government investment supports animal disease surveillance. Medical tourism contributes to specialized veterinary services in select regions. Awareness of zoonotic diseases supports testing demand. Infrastructure gaps influence market penetration. The region presents emerging opportunities for Veterinary Point-of-Care Diagnostics Market Growth.

List of Top Veterinary Point-of-Care Diagnostics Companies

  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Heska Corporation
  • Abaxis
  • Virbac
  • Randox Laboratories
  • Mindray Animal Medical
  • Others

Top Two Companies by Market Share

  • IDEXX Laboratories, Inc.: 29%
  • Zoetis Inc.: 18%

Investment Analysis and Opportunities

Investment activity in the Veterinary Point-of-Care Diagnostics Market is focused on expanding rapid testing capabilities and improving diagnostic accuracy. Companies are investing in the development of portable analyzers and multi-parameter diagnostic kits that support real-time decision-making. Venture capital interest is increasing in digital diagnostics and biosensor-based testing platforms. Expansion into emerging markets attracts funding due to rising pet ownership and livestock health needs. Strategic investments in manufacturing capacity ensure consistent supply of consumables. Partnerships between diagnostic manufacturers and veterinary clinic networks enhance market reach. Investment in software integration supports data-driven veterinary care. Government initiatives supporting animal health surveillance create additional funding opportunities. Private equity interest remains strong due to recurring consumable demand. These factors collectively enhance long-term Veterinary Point-of-Care Diagnostics Market Opportunities.

New Product Development

New product development in the Veterinary Point-of-Care Diagnostics Market emphasizes innovation in speed, accuracy, and usability. Manufacturers are introducing next-generation diagnostic kits capable of detecting multiple conditions from a single sample. Compact analyzers with enhanced sensitivity are improving in-clinic diagnostic confidence. Wireless connectivity and cloud-based reporting systems are being integrated into diagnostic instruments. Development of non-invasive testing methods supports animal comfort and compliance. Advances in microfluidics and biosensor technology enhance performance reliability. User-friendly interfaces reduce training requirements. Battery-operated portable devices expand field-testing capabilities. Continuous reagent improvement supports consistent results. These innovations strengthen the competitive landscape and reinforce the Veterinary Point-of-Care Diagnostics Industry Outlook.

Five Recent Developments (2023–2025)

  • Launch of multi-analyte rapid diagnostic kits for companion animals
  • Introduction of compact, cloud-connected veterinary diagnostic analyzers
  • Expansion of point-of-care infectious disease testing portfolios
  • Strategic partnerships between diagnostics manufacturers and veterinary clinic networks
  • Development of portable diagnostic devices for field and home-care use

Report Coverage of Veterinary Point-of-Care Diagnostics Market

The Veterinary Point-of-Care Diagnostics Market Report provides comprehensive coverage of the global industry landscape. It includes detailed analysis of market structure, segmentation by type, application, and end user, and regional performance evaluation. The report examines key market trends, drivers, restraints, opportunities, and challenges shaping industry dynamics. Competitive landscape assessment profiles leading companies and their strategic initiatives. Innovation pipelines and recent product developments are thoroughly reviewed. Investment patterns and expansion strategies are analyzed to support strategic planning. Market insights are designed to assist stakeholders in decision-making. The report serves as a strategic resource for manufacturers, investors, and veterinary healthcare providers operating within the Veterinary Point-of-Care Diagnostics Market.

Request for Customization   to gain extensive market insights.

 SEGMENTATION

 DETAILS

By Type

·      Kits

·      Instruments

By Application

·      Hormone Level Testing

·      Infectious Disease Testing

·      Others

By End User

·      Veterinary Hospitals

·      Home Care Settings

·      Veterinary Clinics

·      Others

By Geography

·      North America (USA and Canada)

·      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

·      Latin America (Brazil, Mexico and Rest of Latin America)

·      Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

 



  • 2021-2034
  • 2025
  • 2021-2024
  • 128
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann